Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)

ClinicalTrials.gov ID: NCT01060878

Public ClinicalTrials.gov record NCT01060878. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 12:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety and Tolerability of PYM50028 in Subjects With Early-stage Parkinson's Disease Administered Once Daily for 28 Weeks

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to test the therapeutic benefit of the compound PYM50028, versus placebo, in treating early-stage Parkinson's disease. Therapeutic benefit will be assessed using the Unified Parkinson's Disease Rating Scale (UPDRS). It is hypothesised that PYM50028 will be safe and well tolerated in this study and demonstrate therapeutic benefit in this patient population.

Study identification

NCT ID
NCT01060878
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Phytopharm
Industry
Enrollment
425 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
35 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2010 (Type not available)
Primary completion
Dec 2012 (Actual)
Completion
Dec 2012 (Actual)
Last update posted
Mar 4, 2013

2010 – 2012

United States locations

U.S. sites
41
U.S. states
24
U.S. cities
40
Facility City State ZIP Site status
Mayo Clinic Scottsdale Arizona 85259 —
University of California, Irvine Irvine California 92697 —
Coastal Neurological Medical Group La Jolla California 92037 —
Cedars Sinai Medical Center Los Angeles California 90048 —
Pacific Neuroscience Oxnard California 93030 —
Ellison Ambulatory Care Center Sacramento California 95817 —
The Parkinson's Institute Sunnyvale California 94085 —
Colorado Neurological Institute, Rocky Mountain Movement Disorders Center Englewood Colorado 80113 —
Hartford Hospital Manchester Connecticut 06040 —
Institute for Neurodegenerative Disorders New Haven Connecticut 06510 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
University of Florida Center for Movement Disorders and Neurorestoration Gainesville Florida 32607 —
Neurology Clinical Research Inc Sunrise Florida 33351 —
University of South Florida Tampa Florida 33606 —
Emory University Atlanta Georgia 30329 —
Medical College of Georgia Augusta Georgia 30912 —
Elks Rehab - Movement Disorders Center Boise Idaho 83702 —
Northwestern University Chicago Illinois 60611 —
Rush University Medical Center Neuroscience Inst. Chicago Illinois 60612 —
Southern Illinois University School of Medicine Springfield Illinois 62794 —
The University of Kansas Medical Center Kansas City Kansas 66160 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Henry Ford Health Center West Bloomfield Michigan 48322 —
Struthers Parkinson's Center Golden Valley Minnesota 55427 —
Washington University School of Medicine St Louis Missouri 63110 —
Atlantic Neuroscience Institute Morristown New Jersey 07902 —
Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
North Shore University Hospital Manhasset New York 11030 —
Weil Medical College of Cornell University New York New York 10021 —
Duke Parkinson Center Durham North Carolina 27705 —
University of Cincinnati Physicians Cincinnati Ohio 45219 —
Neurological Institute, Cleveland Clinic Cleveland Ohio 44195 —
University of Toledo Toledo Ohio 43614 —
University of Pennsylvania Philadelphia Pennsylvania 19107 —
University of Pittsburgh Pittsburgh Pennsylvania 15260 —
Medical University of South Carolina Charleston South Carolina 29401 —
University of Tennessee Health Science Center Memphis Tennessee 38163 —
Baylor College of Medicine Houston Texas 77030 —
University of Utah Salt Lake City Utah 84108 —
University of Virginia Adult Neurology Charlottesville Virginia 22903 —
Wisconsin Institute for Neurologic and Sleep Disorders Milwaukee Wisconsin 53233 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01060878, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 4, 2013 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01060878 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →